1. [prescribing information],2021
2. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018
3. Tisagenlecleucel in pediatric and young adult patients (pts) with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL): final analyses from the ELIANA study;Rives,2022
4. An updated analysis of tisagenlecleucel in pediatric/young adult patients with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL) in a US multicenter clinical trial (ENSIGN);Maude,2018
5. Use of CD19-directed CAR T-cell therapy in an infant with refractory acute lymphoblastic leukemia;Breese;J Pediatr Hematol Oncol,2021